As I had predicted almost a year ago, on December 14th Opexa executed another reverse split. This time it was 1:4. Since then, their stock has fallen an additional 35.2% in value. This does not seem to put them in a good position for their ongoing trial of Tovaxin (Tcelna) with SPMS.
http://www.opexatherapeutics.com/121412 ... cle=121412
NHE
Opexa reverse split
-
- Similar Topics
- Replies
- Views
- Last post
-
- 5 Replies
- 2574 Views
-
Last post by Petr75